News

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
TMCnet14d
Advarra Integrates Study Startup and IRB Technologies, Enabling Unprecedented Visibility into Clinical Trial Site Activation
New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites .
The Victoria Advocate14d
Advarra Integrates Study Startup and IRB Technologies, Enabling Unprecedented Visibility into Clinical Trial Site Activation
New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites Already ...